Medicines Corner

Generic HIV treatments permit cost savings, but their implementation can be complex

February 2020 | By Martin Bradley

National spending on specialised services for the treatment of HIV is significant; in 2016/17, it was close to £540 million, of which antiretroviral treatment (ART) […]

A gloved hand holding a petri dish containing an aspergillus fungal colony

The new Commissioning for Quality and Innovation indicator on antifungal stewardship

November 2019 | By Martin Bradley

Antimicrobial stewardship is a healthcare system-wide approach to promoting and monitoring the judicious use of antimicrobials, such as antifungals, to preserve their future effectiveness.1 Such […]

Mexiletine: now licensed for myotonia, but what about arrhythmia?

September 2019 | By Martin Bradley

Mexiletine is a sodium channel blocker, and was originally developed as an anticonvulsant drug.1,2 However, it was found to have anti-arrhythmic properties, and has been […]

IVIg: new commissioning criteria and sub-regional panels

May 2019 | By Martin Bradley

As this journal has previously highlighted, continuity of intravenous immunoglobulin (IVIg) supply is a long-standing issue for the NHS. There have been several significant supply […]

New legislation for cannabis-based products for medicinal use

February 2019 | By Martin Bradley

Martin Bradley outlines provisional guidance on when medical cannabis can be prescribed, ahead of a forthcoming NICE guideline

CAR-T Therapy: Innovative Treatment with Special Requirements

November 2018 | By Martin Bradley

Martin Bradley details how this new type of therapy that uses a patient’s own T-cells can be delivered in practice

Articles